ALAMEDA, Calif., April 21 /PRNewswire-FirstCall/ -- Avigen, Inc. , a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, will hold its quarterly conference call to discuss first quarter results on Thursday, April 27, 2006, at 9:00 a.m. EDT (6:00 a.m. PDT). Ken Chahine, Chief Executive Officer, and Michael Coffee, Chief Business Officer, can be heard by calling 866-543-6403 (US) or 617-213-8896 (non-US locations) using passcode 49221759.
This call is being webcast by Thomson/CCBN and can be accessed at Avigen’s web site at http://www.avigen.com. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson’s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.
A rebroadcast of the call will be available shortly after the conclusion of the session and remain available until May 11, 2006. The replay may be accessed over the Internet at http://www.avigen.com or by calling 888-286-8010 (US) or 617-801-6888 (non-US locations) using passcode 92327417.
About Avigen
Avigen, Inc. is a biopharmaceutical company focused on unique small molecule therapeutics and biologics to treat serious, chronic neurological disorders, including neuropathic pain and neuromuscular spasm and spasticity. For press releases and other corporate information, visit our website at http://www.avigen.com.
Avigen, Inc.
CONTACT: Michael Coffee, Chief Business Officer of Avigen, Inc.,+1-510-748-7372, or ir@avigen.com
Web site: http://www.avigen.com/
